Cleared Traditional

K983027 - TRIMETHOPRIM/SULPHAMETHOXAZOLE

K983027 is the FDA 510(k) clearance for TRIMETHOPRIM/SULPHAMETHOXAZOLE by Ab Biodisk. It is a Class 2 Microbiology device (product code JWY) cleared through the Traditional 510(k) pathway after a 32-day FDA review.

K983027 · Ab Biodisk · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1998
Decision
32d
Days
Class 2
Risk

K983027 is an FDA 510(k) clearance for the TRIMETHOPRIM/SULPHAMETHOXAZOLE. Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Ab Biodisk (Solna, SE). The FDA issued a Cleared decision on October 2, 1998 after a review of 32 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ab Biodisk devices

Submission Details

510(k) Number K983027 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1998
Decision Date October 02, 1998
Days to Decision 32 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 102d · This submission: 32d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 360
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K983027.
SYSTEM U3 FOR TETRACYCLINE
K983571 · Ab Biodisk · Dec 1998
SYSTEM U3 FOR NORFLOXACIN
K983486 · Ab Biodisk · Dec 1998
SYSTEM U3 FOR TRIMETHOPRIM/SULFAMETHOXAZOLE
K983259 · Ab Biodisk · Nov 1998
ETEST RIFAMPICIN WITH INDICATIONS FOR S. PNEUMONIAE
K982868 · Ab Biodisk · Sep 1998
SYSTEM U3 FOR CIPROFLOXACIN
K981639 · Ab Biodisk · Sep 1998
ETEST CEFDINIR
K980877 · Ab Biodisk · Jul 1998